Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
07/2007
07/03/2007US7238692 Stent or a drug delivery or elution device with a disposed traiazine compound such as 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine for inhibiting smooth muscle proliferation; restenosis and atherosclerosis
07/03/2007US7238691 Piperidine derivatives and their use as modulators of chemokine (especially CCR3) activity
07/03/2007US7238689 Crop and weed selectivity
07/03/2007US7238688 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
07/03/2007US7238685 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating vasoconstriction, proliferation and inflammation
07/03/2007US7238679 novel family of quinazolines (and pharmaceutically acceptable derivatives thereof that have a range of useful biological and pharmacological properties
07/03/2007CA2273959C Helium-neon excitable reticulocyte dyes derivable from halolepidines
07/03/2007CA2252465C Urea derivatives as inhibitors of impdh enzyme
07/03/2007CA2168021C Vasoconstrictive dihydrobenzopyran derivatives
06/2007
06/28/2007WO2007073300A1 Gaba-b receptor modulators
06/28/2007WO2007073296A1 Heterocyclic gaba-b modulators
06/28/2007WO2007072164A2 Estrogen modulators
06/28/2007WO2007072088A1 Process for the production of ezetimibe and intermediates used in this proces
06/28/2007WO2007071961A1 Benzamide derivatives
06/28/2007WO2007071956A1 Novel benzamide derivatives
06/28/2007WO2007071952A1 Piperazine compounds useful as antagonists of c-c chemokines (ccr2b and ccr5) for the treatment of inflammatory diseases
06/28/2007WO2007071752A2 Pyrimidinyl aryl urea derivatives being fgf inhibitors
06/28/2007WO2007071742A1 Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof
06/28/2007WO2007071598A1 Aryl-isoxazolo-4-yl-oxadiazole derivatives
06/28/2007WO2007071455A1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs
06/28/2007WO2007071434A1 Antiviral 2-carboxy-thiophene compounds
06/28/2007WO2007071358A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
06/28/2007WO2007071199A1 2,4-disubstituted amido-6-substituted-[1,3,5]triazine or 1,3-pyrimidine compounds, their processes for preparation, their pharmaceutical compositions and uses thereof
06/28/2007WO2007054444A3 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives
06/28/2007WO2007053499A3 Compounds useful as antagonists of ccr2
06/28/2007WO2007044724A3 Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3
06/28/2007WO2007035430A3 Process for the preparation of benzo [e] [1,2,4] triazepin-2-one derivatives
06/28/2007WO2007022938A3 Compounds
06/28/2007WO2007005531A3 Alkenyldiarylmethanes, fused analogs and syntheses thereof
06/28/2007WO2006116526A3 Polymorph form ii of tanaproget
06/28/2007US20070149784 Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative
06/28/2007US20070149589 Process for the Preparation of 4-(benzimidazolylmethylamino)benzamidines
06/28/2007US20070149579 e.g. 4-bromo-N-{[4-(4-fluorophenyl)-2-oxo-2H-chromen-7-yl]methyl}-N-{5-[1-hydroxy-1-(trifluoromethyl)propyl]-1,3,4-oxadiazol-2-yl}benzamide;leukotriene biosynthesis and 5-lipoxygenase (5-LO); inhibitor; antiatherosclerotic, antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents
06/28/2007US20070149574 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity
06/28/2007US20070149556 Hydroxypyrimidinone derivatives having inhibitory activity against hiv integrase
06/28/2007US20070149549 Prenylation Inhibitors and Methods of Their Synthesis and Use
06/28/2007US20070149547 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
06/28/2007US20070149546 4-Anilino-quinazoline derivatives as antiproliferative agents
06/28/2007US20070149533 Bicyclic compounds with kinase inhibitory activity
06/28/2007US20070149531 Antiviral agents
06/28/2007US20070149530 Antiviral agents
06/28/2007US20070149524 Substituted diketopiperazines and their use as oxytocin antagonists
06/28/2007US20070149522 Method for producing 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
06/28/2007US20070149519 Benzimidazol substituted thiopene derivatives with activity on ikk3
06/28/2007US20070149514 Indole-phenylsulfonamide derivatives used as ppar-delta activating compounds
06/28/2007US20070149513 Vanilloid receptor ligands and their use in treatments
06/28/2007US20070149512 N-Sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions
06/28/2007US20070149511 Substituted oxazolobenzoisothiazole dioxide derivatives method for production and use thereof
06/28/2007US20070149510 Quinazolinone and benzoxazinone derivatives and uses thereof
06/28/2007US20070149503 Anti-migraine spirocycles
06/28/2007US20070149502 Spirocyclic anti-migraine compounds
06/28/2007US20070149500 Compounds, compositions, and methods
06/28/2007US20070148093 Non-terminal method of identifying anti-migraine compounds
06/28/2007US20070144743 Tree mounted well flow interface device
06/28/2007DE102005061429A1 Substituierte Oxazol-Derivate Substituted oxazole derivatives
06/28/2007DE102005061427A1 Substituierte Oxadiazol-Derivate Substituted oxadiazole derivatives
06/28/2007CA2634047A1 Pyrimidinyl aryl urea derivatives being fgf inhibitors
06/28/2007CA2633425A1 Aryl-isoxazolo-4-yl-oxadiazole derivatives
06/28/2007CA2632881A1 Sulfoximine-substituted pyrimidines, their preparation and use as drugs
06/28/2007CA2632021A1 Gaba-b receptor modulators
06/28/2007CA2631991A1 Heterocyclic gaba-b modulators
06/28/2007CA2631832A1 Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof
06/28/2007CA2631347A1 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions
06/28/2007CA2630737A1 Process for the production of ezetimibe and intermediates used in this process
06/28/2007CA2628596A1 Estrogen modulators
06/28/2007CA2627630A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
06/27/2007EP1801108A1 Morpholine compound
06/27/2007EP1801106A2 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
06/27/2007EP1799677A1 Oxazolidinone derivatives as antimicrobials
06/27/2007EP1799676A2 New bicyclic antibiotics
06/27/2007EP1799675A1 Process for preparing optically pure zolmitriptan
06/27/2007EP1799669A1 Heterocyclic substituted bisarylurea derivatives as kinase inhibitors
06/27/2007EP1799666A2 Piperidine derivatives as nk1 antagonists
06/27/2007EP1799659A1 Compounds for nonsense suppression, and methods for their use
06/27/2007EP1799657A1 Isoxazoline derivatives and their use as herbicides
06/27/2007EP1799652A1 N-benzenesulfonyl substituted anilino-pyrimidine analogs
06/27/2007EP1799646A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
06/27/2007EP1799223A2 Arylthiobenzylpiperidine derivates
06/27/2007EP1740574B1 4-amino-5-cyanopyrimidine derivatives
06/27/2007EP1727815B1 Ether derivatives, their manufacture and use as pharmaceutical agents
06/27/2007EP1567525B1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
06/27/2007EP1531812B1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis
06/27/2007EP1485376B1 Compositions useful as inhibitors of protein kinases
06/27/2007EP1280784B1 Biologically active 4h-benzo 1,4|oxazin-3-ones
06/27/2007EP1077955B1 Method for producing isoxazoline-3-yl-acyl benzene
06/27/2007CN1989137A 3- '4- {6-substituted alkanoyl) pyridin-3-yl} -3-phenyl! -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents
06/27/2007CN1989136A 3-[4-(6-{4, 5-dihydroisoxazol -3-yl} pyridin-3-yl)- 3-phenyl]-5 -(1h-1, 2, 3-triazol -1-ylmethyl)-1, 3-oxazolidin- 2-ones as antibacterial agents
06/27/2007CN1989135A 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as mao inhibitors for the treatment of bacterial infections
06/27/2007CN1989134A 3- {4- (pyridin-3-yl) phenyl} -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents
06/27/2007CN1989133A Process for the preparation of aryl substituted oxazolidinones as intermediates for antibacterial agents
06/27/2007CN1989131A Substituted thiophene derivatives as anti-cancer agents
06/27/2007CN1989128A New 4-benzylidene-piperidin derivatives
06/27/2007CN1989124A Quinazolin-4-yl- piperidine and cinnolin-4-yl- piperidine derivatives as pde10 inhibitors for the treatment of cns disorders
06/27/2007CN1989119A 新的苯甲酰脲衍生物 The new benzoyl urea derivatives
06/27/2007CN1989104A Cyclic amide derivatives, and their production and use as antithrombotic agents.
06/27/2007CN1989099A Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases
06/27/2007CN1988906A Acylated piperidine derivatives as melanocortin 4-receptor agonists
06/26/2007US7235669 Epothilone side components
06/26/2007US7235667 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
06/26/2007US7235580 Mitotic kinesin inhibitors
1 ... 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 ... 647